- Home
- VSA vs XBIO Comparison
VSA vs XBIO Comparison
Compare VSA & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSA
- XBIO
- Stock Information
- Founded
- VSA 2002
- XBIO N/A
- Country
- VSA China
- XBIO United States
- Employees
- VSA N/A
- XBIO N/A
- Industry
- VSA
- XBIO Biotechnology: Pharmaceutical Preparations
- Sector
- VSA
- XBIO Health Care
- Exchange
- VSA NYSE
- XBIO Nasdaq
- Market Cap
- VSA 4.2M
- XBIO 4.2M
- IPO Year
- VSA N/A
- XBIO N/A
- Fundamental
- Price
- VSA $0.70
- XBIO $3.06
- Analyst Decision
- VSA
- XBIO Hold
- Analyst Count
- VSA 0
- XBIO 1
- Target Price
- VSA N/A
- XBIO N/A
- AVG Volume (30 Days)
- VSA 187.6K
- XBIO 11.2K
- Earning Date
- VSA 05-21-2025
- XBIO 05-20-2025
- Dividend Yield
- VSA N/A
- XBIO N/A
- EPS Growth
- VSA N/A
- XBIO N/A
- EPS
- VSA N/A
- XBIO N/A
- Revenue
- VSA $190,004,403.00
- XBIO $2,500,284.00
- Revenue This Year
- VSA $97.94
- XBIO $14.23
- Revenue Next Year
- VSA N/A
- XBIO N/A
- P/E Ratio
- VSA N/A
- XBIO N/A
- Revenue Growth
- VSA N/A
- XBIO N/A
- 52 Week Low
- VSA $0.36
- XBIO $2.20
- 52 Week High
- VSA $19,500.00
- XBIO $5.20
- Technical
- Relative Strength Index (RSI)
- VSA N/A
- XBIO 58.94
- Support Level
- VSA N/A
- XBIO $2.78
- Resistance Level
- VSA N/A
- XBIO $3.39
- Average True Range (ATR)
- VSA 0.00
- XBIO 0.22
- MACD
- VSA 0.00
- XBIO 0.09
- Stochastic Oscillator
- VSA 0.00
- XBIO 69.19
About VSA TCTM KIDS IT EDUCATION INC SPON ADS EA REP 5 ORD SHS(POST REV SPLT)
TCTM Kids IT Education Inc engages in the provision of IT-focused education services in Mainland China. The company has a single reportable segment: IT-focused Supplementary STEM Education Services. It offers supplementary science, technology, engineering, and mathematics (STEM) education programs to young children aged between three and eighteen through online teaching models and instructors from online or offline learning centers. The company also operates an education platform that offers distance instruction, classroom-based learning, and online learning modules.
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.